FDA Draft Guidance on Comparative Analyses and Related Comparative Use Human Factors Studies for a Drug-Device Combination Product Submitted in an ANDA:
This draft guidance provides FDA’s current thinking on general HF considerations and tools for developing a generic combination product under ANDA submissions. https://www.fda.gov/media/102349/download
FDA Guidance on Safety Considerations for Product Design to Minimize Medication Errors:
Looking for best practices from the FDA to improve your drug product and container closure design? See this guidance at https://www.fda.gov/media/84903/download
FDA Draft Guidance on Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors:
This guidance focuses on safety considerations for your product’s container label and carton labeling design. https://www.fda.gov/media/85879/download
FDA Perspectives on Human Factors in Device Development:
A great presentation of HF principles for device development can be found at https://www.fda.gov/media/84709/download
The Role of Human Factors Engineering in Combination Product Post Approval Changes (presented at PQRI Conference in 2019):
Expanding your combination product indications post launch? Visit https://pqri.org/wp-content/uploads/2019/04/1-PQRI-April-2019_CDER-HF-Presentation_QNguyen.pdf for information about how HFE can be applied.
Get More Done.
Contact Kymanox today by calling 919.246.4896 or sending email to sales@kymanox.com.